By Vincent Cruz

Australian beauty brands are having a moment in the United States. A-Beauty’s reputation for sun care, botanical ingredients, and no-nonsense formulations travels well, and American retailers and marketplaces are actively looking for it. What does not travel is your Australian compliance. Australia and the U.S. regulate cosmetics through completely different agencies, different filings, and different legal concepts, and being fully compliant at home buys you nothing with FDA.

This guide is written for the Australian brand owner planning a U.S. launch: what MoCRA requires of you, where the Australian and U.S. systems diverge, and the specific mistakes that catch Australian brands. For the full compliance picture, start with the MoCRA Compliance Guide for Cosmetic Brands.

The core rule: Australian compliance does not transfer

Everything in this guide follows from one fact: FDA does not recognize Australian compliance as a substitute for U.S. compliance. Specifically:

AICIS registration is not FDA registration. The Australian Industrial Chemicals Introduction Scheme regulates the ingredients in your products as industrial chemicals. It says nothing about your facility, and FDA has never heard of it. MoCRA facility registration is a separate filing about where the product is made.
TGA listing is not FDA listing. If your sunscreen is listed on the Australian Register of Therapeutic Goods, that is an Australian therapeutic goods record. FDA’s product listing system is separate, and sunscreen follows an entirely different U.S. pathway (see the pitfalls section below).
Your ACCC-compliant ingredient label meets an Australian consumer law standard. U.S. labeling law has its own rules on format, placement, and content.
There is no Australian equivalent of the U.S. agent requirement. Nothing in the Australian system appoints a U.S.-based contact for FDA, because that role only exists under U.S. law.

Plan your U.S. launch as a fresh compliance project, not an export extension of your Australian paperwork.

Step 1: Register your facility with FDA

If your products are manufactured or processed in Australia (or anywhere outside the U.S.) for sale in America, the facility must register with FDA. Key points for Australian brands:

You need an FEI number first. The FDA Establishment Identifier is required before registration can be filed. Request it from FDA by email; processing typically takes 7 to 10 business days. Run the free FEI check to see whether your facility already has one.
Registration is filed through Cosmetics Direct, FDA’s online portal, using Form FDA 5066. The step-by-step process is covered in Cosmetics Direct: How to Register Your Facility.
Registration renews every two years, based on your facility’s initial registration date, with automated reminders from FDA. See MoCRA Biennial Renewal Explained.
Using an Australian contract manufacturer? The facility that manufactures the product is the one that registers. If a lab in Melbourne or Brisbane makes your products, that lab’s facility registers, and it needs its own U.S. agent. See Private Label Cosmetics: Who Registers Under MoCRA.

A common Australian-brand mistake: assuming your U.S. distributor’s or 3PL’s paperwork covers your factory. It does not. The manufacturing facility registers; a distributor cannot register on the manufacturer’s behalf.

Step 2: Name a U.S. agent

Every foreign facility registering with FDA must designate a U.S. agent: a person or business physically present in the United States who serves as FDA’s official contact for the facility. This is not optional, and an Australian address, your AICIS-registered introducer, or your freight forwarder cannot fill the role.

The agent receives FDA correspondence, relays it to you, and is the contact FDA reaches out to with questions about your facility. This matters more than most Australian brands expect: you are 14 to 17 time zones away from FDA’s business hours, so the agent is the person who gets the call you would otherwise sleep through. For how to evaluate providers, see How to Choose a MoCRA U.S. Agent and Who Can Be a MoCRA U.S. Agent.

Step 3: List your products

Each cosmetic product sold in the U.S. must be listed with FDA through Cosmetics Direct (Form FDA 5067), filed by the responsible person (the manufacturer, packer, or distributor whose name appears on the label). Listings include product and ingredient information and must be kept current with annual updates.

Australia has no direct equivalent of this step. AICIS categorises and tracks ingredients, not finished products, so Australian brands often assume no product-level filing exists anywhere. In the U.S. it does, and skipping it is one of the most common gaps in an Australian brand’s launch. For how registration and listing differ, see Facility Registration vs Product Listing Explained.

Step 4: Fix your labels for the U.S. market

Australian labels do not automatically comply with U.S. labeling law. The differences that matter most:

Ingredient declaration. Australia and the U.S. both use INCI-style nomenclature, so your ingredient list mostly transfers. But the U.S. requires ingredients in descending order of predominance with specific formatting rules, and FDA is developing fragrance allergen labeling regulations that will add new disclosure requirements.

Net quantity. U.S. consumer commodities must state net quantity in both U.S. customary and metric units (for example, fl oz alongside mL), placed in a specific location on the principal display panel. Australian metric-only labels need updating.

Name and place of business. The label must show the name and place of business of the manufacturer, packer, or distributor. An Australian address alone is acceptable only if the product is not misleading about origin; many Australian brands add their U.S. distributor’s information.

Mandatory warnings. Australian labels carry warnings required by Australian standards and scheduling rules; U.S. law requires its own specific warning statements for certain product types. One set does not satisfy the other.

Language and claims. All required label information must be in English and prominent. More importantly, claims written for the Australian market need re-evaluation: “heals,” “repairs damage,” “anti-inflammatory,” and therapeutic-style claims common in A-Beauty marketing can be drug claims in the U.S. See Is Your Product a Cosmetic or a Drug?.

For the detailed labeling changes MoCRA introduced, see MoCRA Labeling Changes.

The pitfalls that catch Australian brands specifically

The sunscreen trap. Australia regulates primary sunscreens as therapeutic goods through the TGA, with some of the strictest testing in the world. Australian brands reasonably assume this makes U.S. entry easy. It does not. In the U.S., sunscreen is an over-the-counter drug: different registration system, Drug Facts labeling, drug facility standards. Your TGA track record is genuinely impressive and entirely beside the point for FDA’s drug pathway. Get classification advice before building a U.S. launch around a hero sunscreen.
Assuming AICIS covers the facility. AICIS deals in ingredients and introducers. It does not register your factory with anyone, and it does not appoint anyone to deal with FDA.
Botanical and essential oil claims. A-Beauty’s strength is plant-derived ingredients, but claims like “antibacterial tea tree,” “heals eczema,” or “treats acne” are drug claims in the U.S. regardless of how the ingredient is marketed at home.
Relying on the distributor. Your U.S. distributor or retail partner may offer to “handle compliance.” They cannot register your Australian facility or serve as your facility’s U.S. agent unless they formally take on that role and meet FDA’s requirements. Keep control of your own filings.
Small-business exemption confusion. The U.S. small-business exemption (Section 612 of the FD&C Act, 21 U.S.C. section 364h) is based on U.S. sales, not Australian turnover, and it never exempts labeling, safety substantiation, or adverse event reporting. Check the exemption worksheet rather than assuming.
Forgetting the ongoing duties. Registration is not a one-time event: biennial renewal, annual listing updates, adverse event reporting within 15 business days for serious events, and record-keeping that FDA can demand to see. See MoCRA Adverse Event Reporting.

A realistic Australia-to-US launch sequence

Classify every product as cosmetic or drug for the U.S. market (re-do claims and ingredients, not just labels). Sunscreens and therapeutic-style products get decided first.
Confirm whether you qualify for the small-business exemption; if not, proceed with full compliance.
Request your facility’s FEI number (7 to 10 business days).
Choose and appoint your U.S. agent.
File facility registration via Cosmetics Direct.
File product listings.
Finalize U.S.-compliant labels before the first shipment.
Set up adverse event intake and record-keeping from day one.

For realistic timing on each step, see How Long Does MoCRA Facility Registration Take?.

FAQ

Do I need a U.S. agent if I sell through an American distributor?
Yes, if your products are manufactured outside the U.S. The foreign manufacturing facility must designate its own U.S. agent as part of facility registration. Your distributor cannot substitute for this unless it formally serves as the agent and meets FDA’s requirements.

Does my AICIS registration count toward FDA registration?
No. AICIS regulates cosmetic ingredients in Australia; FDA facility registration is a separate U.S. filing about the manufacturing facility itself. One has no effect on the other.

My sunscreen is TGA-listed. Can I sell it in the U.S. as a cosmetic?
No. Sunscreen is an over-the-counter drug in the U.S., with a separate registration and listing system, Drug Facts labeling, and drug manufacturing standards. A TGA listing does not change that pathway.

Are Australian cosmetic labels acceptable in the US?
Usually not without changes. Net quantity declarations, name and place of business, warning statements, and claims all need review against U.S. requirements. Ingredient nomenclature mostly transfers, but formatting rules differ.

Can my Australian company be its own U.S. agent?
No. The U.S. agent must be physically present in the United States (residing there or maintaining a U.S. place of business). An Australian company or employee does not qualify.

How long does the whole process take for an Australian brand?
The FEI request alone takes 7 to 10 business days, and gathering registration details, appointing an agent, and finalizing labels adds more time. Plan for several weeks minimum from a standing start; see How Long Does MoCRA Facility Registration Take? for the full breakdown.

Next step: Australian brand planning a U.S. launch? Contact us for a straight assessment of what your products need, or run the free FEI check to confirm whether your facility already has an FDA Establishment Identifier.